GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (FRA:NZM2) » Definitions » Cyclically Adjusted PB Ratio

Novonesis (Novozymes) B (FRA:NZM2) Cyclically Adjusted PB Ratio : 8.24 (As of Jun. 02, 2025)


View and export this data going back to . Start your Free Trial

What is Novonesis (Novozymes) B Cyclically Adjusted PB Ratio?

As of today (2025-06-02), Novonesis (Novozymes) B's current share price is €62.22. Novonesis (Novozymes) B's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €7.55. Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio for today is 8.24.

The historical rank and industry rank for Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:NZM2' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 6.23   Med: 9.5   Max: 13.83
Current: 8.22

During the past years, Novonesis (Novozymes) B's highest Cyclically Adjusted PB Ratio was 13.83. The lowest was 6.23. And the median was 9.50.

FRA:NZM2's Cyclically Adjusted PB Ratio is ranked worse than
93.16% of 1170 companies
in the Chemicals industry
Industry Median: 1.6 vs FRA:NZM2: 8.22

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Novonesis (Novozymes) B's adjusted book value per share data for the three months ended in Mar. 2025 was €24.090. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €7.55 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novonesis (Novozymes) B Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Cyclically Adjusted PB Ratio Chart

Novonesis (Novozymes) B Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.43 13.63 7.97 8.23 7.78

Novonesis (Novozymes) B Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.23 - 8.70 7.78 7.14

Competitive Comparison of Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio falls into.


;
;

Novonesis (Novozymes) B Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=62.22/7.55
=8.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis (Novozymes) B's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Novonesis (Novozymes) B's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=24.09/120.2000*120.2000
=24.090

Current CPI (Mar. 2025) = 120.2000.

Novonesis (Novozymes) B Quarterly Data

Book Value per Share CPI Adj_Book
201503 4.896 100.200 5.873
201506 4.897 100.300 5.869
201509 4.883 100.200 5.858
201512 5.114 99.800 6.159
201603 4.712 100.200 5.653
201606 4.899 100.600 5.853
201609 4.925 100.200 5.908
201612 5.304 100.300 6.356
201703 4.952 101.200 5.882
201706 4.857 101.200 5.769
201709 4.924 101.800 5.814
201712 5.160 101.300 6.123
201803 4.690 101.700 5.543
201806 4.946 102.300 5.811
201809 5.075 102.400 5.957
201812 5.320 102.100 6.263
201903 5.078 102.900 5.932
201906 5.170 102.900 6.039
201909 5.292 102.900 6.182
201912 5.456 102.900 6.373
202003 5.110 103.300 5.946
202006 5.171 103.200 6.023
202009 5.196 103.500 6.034
202012 5.404 103.400 6.282
202103 5.192 104.300 5.983
202106 5.284 105.000 6.049
202109 5.617 105.800 6.382
202112 5.739 106.600 6.471
202203 5.484 109.900 5.998
202206 5.885 113.600 6.227
202209 6.644 116.400 6.861
202212 6.714 115.900 6.963
202303 6.251 117.300 6.406
202306 6.489 116.400 6.701
202309 6.995 117.400 7.162
202312 6.763 116.700 6.966
202403 0.000 118.400 0.000
202406 23.696 118.500 24.036
202412 23.976 118.900 24.238
202503 24.090 120.200 24.090

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novonesis (Novozymes) B  (FRA:NZM2) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Novonesis (Novozymes) B Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis (Novozymes) B Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines